Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ravidasvir + Danoprevir/r + Ribavirin in HCV GT1
NCT03020095Phase 2Completed
- Sponsor
- Ascletis Pharma Inc.
- Start
- Aug 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ravidasvir in hepatitis C (HCV), sponsored by Ascletis Pharma Inc.. Started Aug 2015; status: completed.
02
Drugs
ravidasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03020095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020095.